ability to identify an ideal cell source for tissue regeneration is still challenging researchers in the stem cell field. The possession of progeny cells to differentiate into other cell types ... benefit cell-based…
currently, are based on the dogma that the glucose is the source of energy of the eukaryotic cell. It is to draw the attention of that, even though our body ... beginning of time, seems that you forget. The concept of…
perfusion seems reasonable for diaphragm scaffold for better cell attachment and penetration. ASCs are promising sources for smooth muscle matrices recellularization. The choice of cell line should be defined
challenge. Cell-sheet technology has already brought promising potential in vascularization. However, endothelial cell source for vascularization is limited due to the difficulties in obtaining endothelial cells from…
already existent therapies. An important aspect of regenerative medicine is detecting clinically significant cell sources to be used as autologus or allogeneic therapies. Due to their accessibility, imunomodulatory…
Since their discovery almost 50 years ago, mesenchymal stem cells have shown great clinical potential in various clinical scenarios owing to their multilineage differentiation potential as well as immunomodulatory…
dimensional tissues for the augmentation or replacement of injured or diseased organs. An appropriate cell source is a fundamental requirement for such approaches. Considerations in selecting a cell source include…
issues that will be addressed in the future are the identification of stem cell sources more suitable for cRBC generation, the translation of cRBC culture methods into clinical grade production ... time all these…
affecting the basic mechanisms of aging, in particular, the age-related loss of stem cells. The transplantation of young bone marrow (BM) to laboratory mice of advanced age, results ... clinical adaptation for aged…
diabetic mice, they correct hyperglycemia within 3-4 weeks. Thus human iPS cells are an alternative source of pancreatic beta cells that can be harnessed for the treatment of diabetes
capacity of multilinage differentiation, interestingly they have the capacity to differentiate into hepatocyte like cells. Currently many clinical trials started to involve the usage of self-MSC as a novel ... cirrhotic…
determine whether MenSCs outline common features with bone marrow-derived stem cells (BMSCs) or have source-specific peculiarities, we have done a head-to-head comparison of MenSCs with BMSCs ... using MenSCs for…
area of enzyme-based biofuel cells implanted in biological tissue and operating in vivo. The electrical power extracted from the biological sources presents use for activating microelectronic devices for biomedical…
diabetic mice, they correct hyperglycemia within 3-4 weeks. Thus human iPS cells are an alternative source of pancreatic beta cells that can be harnessed for the treatment of diabetes
field of regenerative medicine requires a reliable source of therapeutic cells in the context of muscular dystrophies. Cell therapies are among the treatment options being considered with the advances ... cells showed…
pacemaker and a wireless signal transfer system powered by implantable biofuel cell extracting electrical energy from biological sources. The design of implanted biofuel cells operating in vivo promises for future…
term-born infants. This study investigated the therapeutic effects of adult-sourced adipose-derived mesenchymal stem cells (MSCs) on motor skills, and on neuronal restoration in the anterior striatum, following
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.